{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1977-N-0023\" and posted_year = 2003 sorted by posted_date descending", "rows": [["FDA-1977-N-0023-0005", "FDA", "FDA-1977-N-0023", "Reference 5 : Verheugt, F. W. et al., \"Effects of Early Intervention with Low Dose Aspirin (100 mg) on Infarct Size, Reinfarction and Mortality in Anterior Wall Acute Myocardial Infarction,\" American Journal of Cardiology, 66:267-270, 1990 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T17:08:47Z", null, 0, 0, "09000064805da1f0"], ["FDA-1977-N-0023-0008", "FDA", "FDA-1977-N-0023", "Reference 9 : Husted, S. E. et al., \"Acetylsalicylic Acid 100 mg and 1,000 mg Daily in Acute Myocardial Infarction Suspects: A Placebo-Controlled Trial,\" Journal of Internal Medicine, 226:303-310, 1989 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T17:34:26Z", null, 0, 0, "09000064805da1f3"], ["FDA-1977-N-0023-0006", "FDA", "FDA-1977-N-0023", "Reference 6 : Hays, L. J. et al., \"Short-term Infarct Vessel Patency with Aspirin and Dipyridamole Started 24 to 36 Hours after Intravenous Streptokinase,\" American Heart Journal, 115:717-721, 1988. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T17:15:00Z", null, 0, 0, "09000064805da1f1"], ["FDA-1977-N-0023-0010", "FDA", "FDA-1977-N-0023", "Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-13T19:04:25Z", null, 0, 0, "09000064805da1f5"], ["FDA-1977-N-0023-0009", "FDA", "FDA-1977-N-0023", "Tab 1.2 - Correspondence re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T18:52:35Z", null, 0, 0, "09000064805da1f4"], ["FDA-1977-N-0023-0012", "FDA", "FDA-1977-N-0023", "Reference 7 : ISIS Pilot Study Investigators, \"Randomized Factorial Trial of High-Dose Intravenous Streptokinase, of Oral Aspirin and of Intravenous Heparin in Acute Myocardial Infarction,\" European Heart Journal 8:634-642, 1987 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T17:21:23Z", null, 0, 0, "09000064805da1f7"], ["FDA-1977-N-0023-0004", "FDA", "FDA-1977-N-0023", "Reference 4 : RISC Group, \"Risk of Myocardial Infarction and Death During Treatment with Low Dose Aspirin and Intravenous Heparin in Men with Unstable Coronary Artery Disease,\" Lancet, 336:827-830, 1990 re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-13T19:06:47Z", null, 0, 0, "09000064805da1ef"], ["FDA-1977-N-0023-0003", "FDA", "FDA-1977-N-0023", "Reference 3 : ISIS-2 (Second International Study of Infarct Survival) Collaborative Group, \"Randomized Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither Among 17,187 Cases of Suspected\nAcute Myocardial Infarction: ISIS-2,\" Lancet, 2:349-360, 1988. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-13T19:06:14Z", null, 0, 0, "09000064805da1ee"], ["FDA-1977-N-0023-0011", "FDA", "FDA-1977-N-0023", "Tab 1.1 - References (3 through 9) re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-13T19:05:34Z", null, 0, 0, "09000064805da1f6"], ["FDA-1977-N-0023-0007", "FDA", "FDA-1977-N-0023", "Reference 8 : Elwood, P. C., and W. 0. Williams, \"A Randomized Controlled Trial of Aspirin in the Prevention of Early Mortality in Myocardial Infarction,\" Journal of the Royal College of General Practitioners, 29:413-416, 1979. re: Background Material from FDA", "Supporting & Related Material", "Background Material", "2003-06-17T04:00:00Z", 2003, 6, null, null, "2019-02-12T17:30:23Z", null, 0, 0, "09000064805da1f2"]], "truncated": false, "filtered_table_rows_count": 10, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1977-N-0023", "p1": "2003"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003", "results": [{"value": "FDA", "label": "FDA", "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003&document_type=Supporting+%26+Related+Material", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003", "results": [{"value": 2003, "label": 2003, "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0023", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003&_facet_date=posted_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1977-N-0023&posted_year=2003&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 889.6205010241829, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}